Cellecta, Inc.
Paul Diehl has a wealth of experience in the biotech industry, with a background in biochemistry and biology. He has held various positions such as Chief Operating Officer, Director of Business Development, and Marketing Director at companies like Cellecta, Inc. and Display Systems Biotech. With a Ph.D. in Biochemistry from Washington State University, Paul has expertise in managing marketing strategy, new product launches, sales training, and overseeing operations. His work focuses on providing custom and contract CRISPR/RNAi screening and expression profiling products and services to biomedical research laboratories.
This person is not in any teams
Cellecta, Inc.
1 followers
Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets. We offer pooled lentiviral shRNA and CRISPR libraries, pooled library screening and analysis by NGS, targeted RNA-Seq for biomarker discovery, lentiviral reagents, and stable cDNA, shRNA, and CRISPR constructs and isogenic cell lines.